In accordance to observations in would healing, overexpression of Flii led to a more severe clinical phenotype in antibody transfer-induced EBA (408), while pharmacological inhibition had therapeutic effects in mice with EBA (409). Here, FLII is linked to acquired epidermolysis bullosa.